EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to discuss and critique the management techniques of pediatric cholesteatoma such as intact wall versus open cavity, second look and ossicular reconstruction.
EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to discuss the impact of oral corticosteroid therapy on the decision to perform surgery in patients with chronic rhinosinusitis.
OBJECTIVES:
The purpose of this study was to determine whether oral steroids alter the management of chronic rhinosinusitis (CRS) patients meeting criteria for endoscopic sinus surgery. STUDY DESIGN: Prospective, academic tertiary care setting. METHODS: 64 consecutive patients were studied who had clinical and radiographic evidence of CRS that was unresponsive to at least 6 weeks of oral antibiotics, decongestants, saline washes, and topical nasal steroid sprays. The patients were additionally treated with a month long taper of oral methylprednisolone and then reevaluated by sinonasal endoscopy and CT. They were subsequently followed for the next 24 months. RESULTS: Out of the 64 patients, 23 had polypoid sinusitis and 35 had previous endoscopic sinus surgery. By endoscopic appearance and Lund-Mackay CT score, 80% were improved immediately following systemic corticosteroid therapy. 69% had at least transient improvement in their symptoms. Over the next 24 months 57% went on to undergo endoscopic sinus surgery. The remaining patients continued to be managed medically as necessary and did not require surgery over this interval to achieve acceptable control over their symptoms. CONCLUSIONS: In a subset of CRS patients who might otherwise be candidates for endoscopic sinus surgery, the addition of oral corticosteroids to the maximal medical therapy regimen prior to surgery appears to alter management. This applies equally to patients with or without previous surgery and those with polypoid or nonpolypoid disease. Further studies are necessary to determine the optimal corticosteroid dosage and to identify patient factors that predict where systemic corticosteroids are most likely to be beneficial.
To demonstrate the use of a novel technique in the repair of cutaneous helical rim defects using a single staged transposition flap. STUDY DESIGN: Case study. METHODS: Three patients who underwent Mohs micrographic surgery of cutaneous cancers of the helical rim were repaired using a single staged transposition flap. RESULTS: All three patients were noted to have repair of the helical rim contour with minimal cosmetic deformity, minimal donor site morbidity, and excellent tissue match. CONCLUSIONS: The single staged transposition flap offers many advantages over previously described techniques. It is easy to design, can be performed in a single stage, results in restoration of the helical rim contour, and results in minimal donor site morbidity.
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Lateral Crus Lateralization for Nasal Valve Collapse Todd A. Kupferman, MD, Shreveport, LA Timothy S. Lian, MD, Shreveport, LA Fredrick J. Stucker, MD*, Shreveport, LA EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to describe a simple, effective treatment for nasal valve collapse.
OBJECTIVES:
To describe a simple, effective method for correction of nasal valve stenosis. STUDY DESIGN: A case series of 4 patients. METHODS: This method has been performed by the senior author on dozens of patients with long lasting improvement. Nasal valve collapse was diagnosed by: history of nasal obstruction relieved with pulling nose laterally either with fingers or adhesive strips; physical exam which revealed inward excursion of nasal sidewalls on nasal inspiration, relieved with the Cottle maneuver; and nasal endoscopy which was negative for masses or other causes of nasal obstruction. Via an open rhinoplasty approach, the lateral crus of the lower lateral cartilage is separated from the upper lateral cartilage, pulled lateral relative to the upper lateral cartilage, and reattached with mattress sutures to the upper lateral cartilage in the new lateral position. RESULTS: All patients underwent the procedure via an open/external rhinoplasty approach specifically to correct their nasal valve stenosis. All patients reported improvement in their nasal airflow in the recovery room and postoperative visits. CONCLUSIONS: Lateral crus lateralization offers surgeons a simple and effective method of correcting nasal valve collapse through a well known approach without bulky grafts or incisions outside the nose. EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to explain the role of matrix metalloproteases and protease inhibitors in the resorption of a commonly used acellular dermis matrix.
To determine if the resorption of a commonly used acellular dermal graft in soft tissue augmentation can be altered by a broad-spectrum inhibitor of matrix metalloproteinases. STUDY DESIGN: Laboratory based study. METHODS: The degradation of acellular human dermis (Alloderm) specimens was tested in vivo and then in vitro. Acellular human dermis was implanted subcutaneously within guinea pigs after treatment with buffered saline or a peptidyl hydroxamic acid exogenous matrix metalloproteinase (MMP) inhibitor (Galardin, GM6001). Specimens were then removed for histological analysis at 14 and 21 days. Wild type murine fibroblasts as well as those derived from mice deficient in MMP2 were placed atop the basement membrane surface of acellular human dermis and in vitro resorption was assessed. GM6001 was added to specimens cultured with wild type fibroblasts. Specimens were harvested for histological analysis after 20 days. RESULTS: Inflammatory host cell infiltration within the ADM specimens pretreated with GM6001 was significantly less than that found in control specimens both at 14 (139 versus 243 cells, p=0.008) and 21 days (75 versus 108 cells, p=0.002). There was no evidence of neovascularity within any of the specimens. The basement membrane thickness of the specimens cultured with wild-type fibroblasts (15.95 ¼m) was significantly less than those cultured with GM6001 (19.85 ¼m, p<0.001), MMP2-deficient fibroblasts (20.11 ¼m, p=0.001) and also native Alloderm (22.64 ¼m, p<0.001) CONCLUSIONS: The results from our in vitro experiments suggest that MMP2 may play an important role in the resorption of acellular human dermis. The addition of a broad spectrum protease inhibitor such as GM6001 appears to slow cellular penetration and matrix degradation in vivo and in vitro. 40.8 (range, 19-73) . Twenty-nine of these patients were eligible for minimally invasive thyroidectomy (MITh) and 16 underwent conventional thyroidectomy. The mean incision length in the MITh cohort was 4.9 cm and for the conventional thyroidectomy patients it was 9.6 cm. The mean surgical time for a hemithyroidectomy was 117.9 minutes in the MITh group (n=18) and 149.4 minutes (n=5) for conventional thyroidectomy; for total thyroidectomy the surgical times were 137.2 minutes (n=11) and 184.3 minutes (n=11), respectively. There were no cases of permanent hypocalcemia or recurrent laryngeal nerve paralysis in either group. No patients in the MITh group had to be converted to a conventional thyroidectomy. The cosmetic results were excellent, although two patients described mild paraincisional discomfort and one patient in the MITh group developed a mildly hypertrophic scar which responded to triamcinolone injection. CONCLUSIONS: Minimally invasive thyroidectomy is safe in carefully selected patients and probably results in more rapid wound healing. The cosmetic result is superior to that achieved with conventional thyroidectomy.
9:18 Surgical Management of Nasopharyngeal Juvenile Angiofibroma With Intracranial Extension
Victor L. Schramm Jr., MD, Denver, CO Mario J. Imola, MD DDS, Denver, CO EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to understand the indications and outcome for surgical resection of nasopharyngeal angiofibroma with intracranial extensions
OBJECTIVES:
To determine the efficacy of applying craniofacial-skull base surgery techniques for the resection of nasopharyngeal angiofibroma extending intracranially. STUDY DESIGN: Retrospective analysis of 20 patients found to have intracranial extension of nasopharyngeal managed by the same surgeon at a tertiary care hospital facility. METHODS: The clinical and hospital records, pathology and radiographs of 20 patients with nasopharyngeal angiofibroma were reviewed. Follow-up information was obtained from clinical observation and from our tumor registry. RESULTS: Twenty patients were treated between 1982 and 2002 with combined transoraltranspalatal and lateral preauricular skull base resection. The temporomandibular joint contents were transposed in 12 patients and 3 had a limited contralateral external ethmoid approach. The intracranial extensions eroded bone, trigeminal nerve, compressed the cavernous sinus and involved the dura but were removed without need for other therapy. Blood replacement ranged from 2-5 units (mean 3) and was unaffected by pre-operative tumor embolization. Temporary 6th and 7th cranial nerve paralysis was noted in 5 patients. Trigeminal nerve branch resection was required in 10 patients. Functional and cosmetic sequelae has been limited to atrophy of the temporales muscle and an open jaw shift toward the operative side with normal occlusion. All patients are currently free of disease (mean follow up 8 years) though two have required secondary resection of a buccal persistence. CONCLUSIONS: It is appropriate to treat intracranial extensions of nasopharyngeal angiofibroma surgically utilizing skull base operative techniques. Angiography and embolization may be unnecessary. Cosmetic and functional outcomes are improved by avoiding facial incisions and condylectomy EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to discuss a murine sarcoma model and understand the implications of combined tumor suppressive and immunosuppressive efficacy of everolimus in the setting of laryngeal reconstruction.
OBJECTIVES: Everolimus (RAD), a derivative of the immunosuppressant rapamycin, has been shown to prevent acute rejection in the rat laryngeal transplant model. This study was undertaken to investigate the tumor suppressive efficacy of everolimus at laryngeal allograft sparing doses. STUDY DESIGN: A dose efficacy study employing a murine sarcoma model. METHODS: Forty-five 10 week old inbred C57 BL-6 mice underwent subcutaneous inoculation of 1 x 106 MCA 205 sarcoma cells. On the third post-inoculation day the mice were divided into 4 treatment groups undergoing daily gavage with everolimus 0, 0.2, 1.0, and 5.0 mg/kg/day. On the 13th postinoculation day all treatment was discontinued. Mean tumor size was measured every 2 days during treatment, and biweekly until sacrifice on the 31st post-inoculation day. Mean whole blood trough levels (Cmin) of everolimus were measured for each group. RESULTS: Mice treated with 1 and 5 mg/kg/day of everolimus experienced significant inhibition of tumor growth between the 7th and 23rd post-inoculation days (p<0.0001) with an approximate 50% reduction in mean tumor size. Treatment with 0.2 mg/kg/day of everolimus was not associated with a significant difference in mean tumor size when compared with controls. Mean tumor suppressive whole blood Cmins for the 1 and 5 mg/kg/day groups were 75.6 and 368.9 ng/ml, respectively. CONCLUSIONS: Treatment with 1 and 5 mg/kg/day of everolimus was associated with a significant reduction in mean tumor size among mice inoculated with MCA 205 sarcoma cells. Mean effective tumor suppressive concentrations of everolimus ranged from 75.6 to 368.9 ng/ml.
9:34 Chemoradiation Induced Cell Loss in Adult Human Submandibular Glands
Christopher A. Sullivan, MD, Boston, MA EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to describe the features of chemoradiation damage to human salivary glands and to discuss a novel approach to the treatment of chemoradiation induced xerostomia.
OBJECTIVES:
Chemoradiation induced xerostomia affects approximately 40,000 head and neck cancer patients annually in the United States. No human histopathologic or cytochemical data exists that characterizes chemoradiation related salivary gland damage. The objective of this study was to describe the histopathologic and cytochemical features of the non-acute phase of human submandibular gland damage after chemoradiation therapy. STUDY DESIGN: Case control clinicopathologic study. METHODS: Pathology slides and cell blocks were obtained from patients who had undergone neck dissection after protocol driven chemoradiotherapy for stage IV head and neck cancer at a tertiary head and neck cancer institute. Histologic and cytochemical analyses were performed on representative sections of chemoradiated submandibular glands and findings were compared to age and sex matched, untreated control glands. RESULTS: Forty patients were identified who had undergone neck dissection an average of eight weeks after treatment with induction chemotherapy and chemoradiation therapy for nonoral head and neck cancer. In the chemoradiated glands light microscopic findings included decreased numbers of acinar cells, interstitial edema, vacuolization, fibrosis, and loss of granules in the convoluted tubules when compared to controls. Microvascular density was unaffected by chemoradiation; cytokeratin staining showed no change in ductal epithelium when compared to controls. CONCLUSIONS: Non-acute changes seen in human submandibular glands after chemoradiation therapy are compared to those seen in previously described irradiated animal models. Primary dysfunction in humans appears to be related to a reduction in function and number of submandibular gland acinar cells. The ductal system appears unaffected by chemoradiation therapy. Implications for management of xerostomia are discussed. EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to discuss the factors which influence the metastasis of squamous cell carcinoma to the posterior triangle of the neck.
Surgical modifications sparing uninvolved structures such as the spinal accessory nerve have been implemented since the advent of the radical neck dissection. The increased morbidity to the spinal accessory nerve involved with the dissection of level V lymph nodes has led to much controversy. In this study, we examine the incidence of nodal metastasis to all nodal levels involved with upper aerodigestive squamous cell carcinoma and attempt to determine factors predictive of level V nodal metastasis. STUDY DESIGN: Retrospective chart review. METHODS: A retrospective review on all pathology reports obtained from patients that underwent a radical or modified radical neck dissection between 1996 and 2003 from two institutions. Statistical analyses were performed to determine clinical and pathological factors that were significantly associated with level V metastasis. RESULTS: 79 patients with a total of 94 neck dissections were analyzed. The prevalence of level V metastasis was 7.4%. Multivariate analysis found that positive lymph nodes involving levels II, III, and IV was the only independent significant factor for level V metastasis (p = 0.001). CONCLUSIONS: Our study is in concordance with the literature, in revealing a low prevalence of level V metastasis. Our study goes further to suggest that if levels II, III, IV are found to be positive intraoperatively, then dissection of level V should be performed. Otherwise, the dissection of level V is not warranted and may lead to added morbidity to the spinal accessory nerve.
10:38 Lymph Node Metastases in Cutaneous Squamous Cell Carcinoma: A Prospective Evaluation
Brian A. Moore, MD, Houston, TX Randal S. Weber, MD*, Houston, TX Victor Prieto, MD, Houston, TX Xian Zhou, MS, Houston, TX J. Jack Lee, PhD, Houston, TX Gary L. Clayman, DDS MD, Houston, TX EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to demonstrate an understanding of the incidence, presentation, and associated findings of lymph node metastases in cutaneous squamous cell carcinoma of the head and neck. Participants should be able to discuss contemporary treatment philosophies and understand the prognostic implications of this finding.
OBJECTIVES:
Cutaneous squamous cell carcinoma (CSCC) has been reported to metastasize to parotid and cervical lymphatics. The associated clinical and histopathologic findings of these nodal metastasis have not been prospectively investigated. STUDY DESIGN: Prospective, longitudinal analysis of patients with CSCC at a comprehensive cancer center. METHODS: Eligible patients with CSCC of the head and neck were consecutively enrolled in a prospective database from July 1996 through June 2001; this cohort was then followed to the key endpoints of recurrence and mortality. RESULTS: Two hundred ten patients were enrolled, and 12.9% were found to have clinical or pathologic evidence of lymph node metastases in either the parotid gland or neck. Median follow-up was 18.3 months in patients with lymph node metastases and 22 months in patients with no evidence of metastases. Nodal metastases were significantly associated with recurrent lesions (p = 0.05) and the following features: lymphovascular invasion (p = <0.0001), extracapsular extension (p = <0.0001), a positive margin (p = <0.0001), poorly differentiated histology (p = <0.0001), deep invasion into the subcutaneous tissues (p = 0.011), perineural invasion (p = 0.035), and larger size (p = 0.0004). At the conclusion of the study period, 33.3% of patients with nodal metastases developed recurrent disease and 18.5% died of their disease, compared to 15.3% of patients without lymph node spread who recurred and 11.1% who died of disease (p = 0.027). CONCLUSIONS: Lymph node metastases from cutaneous squamous cell carcinoma are common and are associated with a diminished recurrence-free survival. The presence of nodal spread often occurs in the setting of other adverse histopathologic findings, and we recommend aggressive treatment of the parotid and neck in these situations. EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to explain the difference between PET and PET/CT scanning, understand the evidence behind the utilization and accuracy of PET/CT for head and neck tumors, and discuss the implications of PET/CT results in patient management decisions.
10:46 THIRD PRIZE -LLOYD STORRS RESIDENT RESEARCH AWARD Utilization, Accuracy, and Implications for Patient Management of [18F]-2-Fluorodeoxyglucose-Positron Emission/Computerize Tomography (PET/CT) for Head and Neck Tumors

OBJECTIVES:
Positron emission tomography (PET) has shown promise for early cancer detection and accurate staging of cancer patients, and a limited number of studies suggest PET/CT may improve these variables; however, no published study has specifically evaluated PET/CT for head and neck tumors. The current study evaluates the utilization, accuracy, and implications for patient management of PET/CT scans in patients with head and neck (HN) tumors. STUDY DESIGN: Retrospective cohort outcomes study at a tertiary care center. Multiple regression analysis was performed. METHODS: The authors identified 795 consecutive PET/CT scans during the first year of utilization of the PET/CT scanner at our institution. A total of 113 were obtained for HN tumors. Accuracy, utilization, and implications for patient care management decisions were correlated with each PET/CT scan. RESULTS: Accuracy, sensitivity, and specificity were measured by comparing the PET/CT results at the primary tumor site, cervical node sites, and distant sites to either pathologic or definitive clinical diagnoses. PET/CT had an overall per scan accuracy of 69% and per patient accuracy of 72%. When stratification for etiology of obtaining the scan was performed, per scan accuracy of 80% staging distant disease, 58% primary tumor evaluation, 68% recurrence evaluation and 60% unknown primary accuracy was obtained. CONCLUSIONS: PET/CT is a promising tool for head and neck tumors; however, in clinical practice the proper utilization of such technology is not well studied. In our study PET/CT had an overall accuracy of 69% in evaluating HN tumors; and PET/CT had the most accuracy in aiding in the detection of distant metastasis.
OBJECTIVES: Lipoma, a tumor of fat cell origin, is a common benign tumor of the head and neck. This soft tissue tumor is typically discrete and often encapsulated. Surgical excision is sometimes undertaken for cosmetic reasons and for enlarging tumors. Lipomatosis, however, is a more diffuse fatty tissue growth sometimes seen in the extremities, rarely in the head and neck. The objectives of this study are to report a case of lipomatosis of the neck with mediastinal extension in a pediatric patient and present a literature review of lipomatosis of the head and neck. STUDY DESIGN: Case report and review of the English literature. METHODS: A case report is presented with a review of the English literature of lipomatosis involving the head and neck. Clinical presentation with radiographic images and histopathology is presented as well as treatment and follow-up. RESULTS: A 2 1/2 year old female presented with a painless, right supraclavicular mass. Radiologic evaluation of the lesion found it to be extending into the anterior mediastinum. Incisional biopsy and histology were consistent with lipomatosis. The lesion was not excised and at two years follow-up the child remains asymptomatic. Follow-up imaging showed no enlargement of the mass. CONCLUSIONS: Lipomatosis is uncommon in the head and neck region. While treatment has historically been excision, conservative nonoperative management should be considered with asymptomatic disease in which the morbidity and mortality of excision may be high. Routine follow-up with imaging is recommended to monitor the extent and growth of the tumor. EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to classify types of caudal septal deflection, discuss the history of its surgical treatment and compare traditional procedures with the novel technique described herein.
Surgical Treatment of the
OBJECTIVES:
A number of previous papers have described the caudal septal deflection and its surgical treatment. The anatomy of the caudal septum is controversial, as some authors claim that the septum has ligamentous-like attachments with the lower lateral cartilages, while others assert that none exist. Septal cartilage memory and attenuated mucoperichondrial flaps add to the challenge of obtaining long-term success with septoplasty. The aim of this presentation is to review the classification of anterior septal deflections, summarize the surgical options and describe a novel method for its treatment. STUDY DESIGN: Case report and review of the literature. METHODS: A 33 year old female with nasal obstruction and a severe right anteroinferior caudal septal deflection presented for surgical correction. After isolating the deviated cartilage and creating a pocket in the columella, a chromic suture was passed through the posterior aspect of the deflection and brought out between the lower lateral cartilages, thereby "sliding" the septum into place. This "sliding stitch" was secured with mattress sutures which also closed the hemitransfixion incision. The excess suture was cut anteriorly. Subsequently, a comprehensive literature review was performed. RESULTS: The patient has had complete resolution of her nasal obstruction and demonstrated a midline septum on postoperative physical exam. CONCLUSIONS: The "sliding septal stitch" has provided excellent short-term surgical correction of the anteroinferior caudal septal deflection in this case. It should be considered for further study as part of the armamentarium for septoplasty surgeons.
Minimally Invasive Modified Endoscopic Lothrop: Technique for Frontal Recess Mucosa Preservation
Marc G. Dubin, MD, Savannah, GA Frederick A. Kuhn, MD*, Savannah, GA EDUCATIONAL OBJECTIVE: At the completion of the presentation, one should be able to discuss the benefits of the endoscopic intranasal Lothrop performed with frontal sinus punches. Additionally, one should be able to explain the risk of using a drill to perform the procedure as it relates to damage to the lateral mucosa of the frontal recess and alteration of the natural mucociliary clearance of the frontal sinus.
OBJECTIVES:
The modified intranasal endoscopic Lothrop procedure has been popularized as an alternative to frontal sinus obliteration for refractory inflammatory frontal sinus disease. However, the drilling required for this procedure disrupts the lateral frontal recess mucosa. Since frontal sinus mucociliary clearance is down the lateral frontal recess wall, this destruction may lead to altered frontal sinus mucociliary clearance and potential ostium constriction. STUDY DESIGN: Description of technique. METHODS: In two patients an endoscopic modified Lothrop procedure was performed utilizing frontal sinus punches. Bilateral frontal sinusotomies were connected across the midline septum without the use of a drill, sparing the anterior, lateral and posterior frontal recess mucosa. RESULTS: This minimally invasive technique allowed complete preservation of all mucosa of the lateral frontal recesses as well as a majority of the mucosa of the anterior and posterior recess. With an average follow-up of 19.5 months both patients have widely patent and functioning frontal sinuses. CONCLUSIONS: In select patients whose anterior-posterior frontal sinus dimension is adequate to allow removal of the frontal sinus floor and intersinus septum, the modified Lothrop procedure can be performed in a manner that preserves the natural mucociliary clearance of the frontal sinus. The destruction of the lateral mucosa of the frontal recess that almost uniformly occurs with a drill in the frontal recess can be avoided and frontal ostium patency can be maintained.
To obtain normative data for the dimensions of the mastoid antrum in the human temporal bone. STUDY DESIGN: Retrospective review of temporal bone computerized tomography (CT) scans performed at our university. METHODS: The Clinical Image Management System (CIMS) developed at our institution was used to measure temporal bone CT scans performed within the past four years on 100 adult patients, 50 women, 50 men, ages 25-75. Seven planar measurements, five angular measurements, and a volume measurement of the mastoid antrum were made. RESULTS: The mastoid antrum is a tetrahedral shaped space located posterior, lateral, and superior to the labyrinth. The average dimensions were 2.16mm for the aditus, 10.7mm long axis, 3.99mm horizontal axis, and 8.43mm vertical axis. The average volume was 0.32 ml. CONCLUSIONS: Although clear definition of its position relative to other major landmarks has resulted in surgical techniques that allow accurate identification of the mastoid antrum, accurate definition of the location and dimensions of the mastoid antrum beyond these relative positions are lacking. Normative dimensions of the mastoid antrum are defined by this study and give surgeons the ability to classify preoperatively the relative size and surgical tolerances required for safe identification and dissection of the mastoid antrum.
Multiple Spontaneous Encephaloceles Manifesting in a Family
Kevin E. McLaughlin, MD, Monroe, LA EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to explain the etiologies for spontaneous encephaloceles and discuss the pertinent variables that dictate their individual repair as well as the surgical techniques available. One will also be able to discuss the pathophysiology of cerebrospinal fluid as well as the medical and surgical interventions for benign intracranial hypertension.
OBJECTIVES:
Present the first reported case of a mother and daughter with multiple encephaloceles. Their differing presenting symptoms will be reviewed. Their common and differing radiographic findings will be illustrated. Differing aspects of their presentation dictated different surgical interventions. One of the daughter's encephaloceles had the uncommon presentation of including the lateral ventricle extending into the nasal cavity via a frontoethmoid defect. The reasons for treating her with an external approach via traditional craniotomy will be discussed. The mother had a lateral pterygoid recess sphenoid encephalocele, treated endoscopically via a transmaxillary/transpterygoid approach. The reasons for her endoscopic treatment as well as other indications for endoscopic treatment will be discussed. Postoperative monitoring of intracranial pressure will be discussed. Both patients had intracranial hypertension. Medical and surgical treatments for intracranial hypertension will be reviewed. Both patients are doing well more than two years after their surgeries. EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to recognize typical and atypical presentations of cystic hygroma including presentations involving the auricle, external auditory canal and mastoid and discuss techniques for diagnosis and management.
To describe two unique cases of cystic hygroma involving the ear. To discuss the diagnosis and management of cystic hygroma. To review the current literature regarding cystic hygroma. STUDY DESIGN: Case report and literature review. METHODS: The cases of two children with cystic hygroma involving the ear are presented. The clinical and radiologic features, management and outcome are discussed. The current literature regarding cystic hygroma is reviewed. RESULTS: Both patients underwent uncomplicated surgical resection of their cystic hygromas and were free of disease at latest follow-up visit. CONCLUSIONS: Cystic hygroma is a form of lymphangioma that presents in children and, while benign, can develop a pattern of local invasion and recurrence. Diagnosis is based on clinical exam as well as radiographic imaging. Treatment is primarily surgical, although other treatment modalities have been proposed. Cystic hygroma most frequently appears in the posterior neck. These cases are unique in that they involve the auricle, external auditory canal, and mastoid. This underscores the need for increased awareness of atypical presentations of this disease. EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to: 1) recognize the role of prostaglandin E2 in head and neck tumor formation; 2) discuss the mechanism of action of cyclooxygenase inhibitors in reducing prostaglandin E2 production; and 3) recognize the potential chemoprotective effects of cyclooxygenase inhibitors after head and neck cancer treatment.
Association of
OBJECTIVES:
To determine whether chronic use of a cyclooxygenase inhibitor is associated with decreased mortality and decreased disease recurrence after head and neck cancer treatment. STUDY DESIGN: Case control study. METHODS: An electronic patient database was searched to determine the vital status of all patients treated for head and neck squamous cell carcinoma over an 8 year period at a single academic institution. The database was then searched to identify patients who were chronic users of aspirin, nonsteroidal anti-inflammatory medications, or selective COX-2 inhibitors. The rate of cyclooxygenase inhibitor use among patients who had died (cases) was then compared to rate of use among survivors (controls). The comparison was made while controlling for tumor site, tumor stage, treatment received, age, sex, race, and smoking status. RESULTS: A total of 375 patients was treated for head and neck squamous cell carcinoma over the 8 year period examined. Of the 375 patients, 150 patients had died (cases) and 225 were alive (controls) at the time of the study. When the rate of cyclooxygenase inhibitor use was compared between groups, significantly more survivors were users than those who had died of disease (p=0.01). Additional subgroup analysis will investigate whether the type of cyclooxygenase inhibitor (aspirin, nonsteroidal, or selective COX-2) is important in reducing head and neck cancer-related mortality. CONCLUSIONS: Daily use of a cyclooxygenase inhibitor appears to reduce the risk of mortality after head and neck cancer treatment. These findings support the need for a randomized, controlled clinical trial to investigate the chemoprotective effects of these medications in head and neck cancer patients.
Endolymphatic Hydrops Complicating Gamma Knife Radiotherapy for Vestibular Schwannoma
Jayakar V. Nayak, MD PhD, Pittsburgh, PA Elizabeth H. Toh, MD, Pittsburgh, PA Barry E. Hirsch, MD, Pittsburgh, PA Joseph M. Furman, MD PhD, Pittsburgh, PA EDUCATIONAL OBJECTIVE: At the conclusion of this presentation, the participants should be able to discuss anticipated complications of stereotactic radiation treatment for vestibular schwannomas, including clinical manifestations of radiation induced vestibulopathies.
OBJECTIVES:
Stereotactic radiation is an established treatment option for select patients with vestibular schwannomas. Expected complications from this intervention include trigeminal and facial neuropathies, hearing loss and dizziness. We report a patient who developed new onset episodic vertigo with fluctuating audiologic symptoms suggestive of delayed endolymphatic hydrops. STUDY DESIGN: Case report. METHODS: A 50 year old male was evaluated by the otolaryngology service for right-sided progressive hearing loss and tinnitus over a 6 month period without associated vestibular symptoms. An 8mm intracanalicular right vestibular schwannoma was diagnosed on magnetic resonance imaging. After extensive discussion of treatment options, the patient elected to undergo gamma knife radiosurgery as primary treatment. RESULTS: 20.8 Gy of gamma radiation was administered in a single dose using 4 tumor isocenters. Within 5 weeks of this intervention, the patient experienced increased right-sided tinnitus, hyperacusis, diplacusis and hearing loss associated with severe episodic vertigo. Vestibular testing and audiometry showed a right-sided reduced caloric response and progression in low frequency sensorineural hearing loss in the treated ear. He is currently being treated with systemic steroids and diuretics with symptomatic improvement. CONCLUSIONS: This clinical presentation of fluctuating hearing loss with episodic vertigo is suggestive of endolymphatic hydrops in an ear following gamma knife stereotactic radiation treatment for a vestibular schwannoma. This diagnosis is further supported by clinical improvement with diuretic therapy.
